Extracellular targeted protein degradation: an emerging modality for drug discovery
Authors:
Top Cited Papers
- 7 December 2023
- journal article
- review article
- Published by Springer Nature in Nature Reviews Drug Discovery
- Vol. 23 (2) , 126-140
Abstract
Targeted protein degradation (TPD) has emerged in the past decade as a major new drug modality to remove intracellular proteins with bispecific small molecules that recruit the protein of interest (POI) to an E3 ligase for degradation in the proteasome. Unlike classic occupancy-based drugs, intracellular TPD (iTPD) eliminates the target and works catalytically, and so can be more effective and sustained, with lower dose requirements. Recently, this approach has been expanded to the extracellular proteome, including both secreted and membrane proteins. Extracellular targeted protein degradation (eTPD) uses bispecific antibodies, conjugates or small molecules to degrade extracellular POIs by trafficking them to the lysosome for degradation. Here, we focus on recent advances in eTPD, covering degrader systems, targets, molecular designs and parameters to advance them. Now almost any protein, intracellular or extracellular, is addressable in principle with TPD.Keywords
This publication has 122 references indexed in Scilit:
- Engineered Monoclonal Antibody with Novel Antigen-Sweeping Activity In VivoPLOS ONE, 2013
- The Role of the Transmembrane RING Finger Proteins in Cellular and Organelle FunctionMembranes, 2011
- A combinatorial histidine scanning library approach to engineer highly pH‐dependent protein switchesProtein Science, 2011
- Structure-dependent Impairment of Intracellular Apolipoprotein E4 Trafficking and Its Detrimental Effects Are Rescued by Small-molecule Structure CorrectorsJournal of Biological Chemistry, 2011
- Antibodies mediate intracellular immunity through tripartite motif-containing 21 (TRIM21)Proceedings of the National Academy of Sciences, 2010
- Neonatal Fc Receptor: From Immunity to TherapeuticsJournal of Clinical Immunology, 2010
- Pharmacokinetics of Anti-hepcidin Monoclonal Antibody Ab 12B9m and Hepcidin in Cynomolgus MonkeysThe AAPS Journal, 2010
- Targeting the Undruggable Proteome: The Small Molecules of My DreamsChemistry & Biology, 2010
- Structural basis for PRYSPRY-mediated tripartite motif (TRIM) protein functionProceedings of the National Academy of Sciences, 2007
- Aptamers evolved from live cells as effective molecular probes for cancer studyProceedings of the National Academy of Sciences, 2006